TL-118
Sponsors
Tiltan Pharma Ltd.
Conditions
Metastatic Pancreatic CancerPancreatic Cancer
Phase 2
A Clinical Trial of Anti-Angiogenic Drug Combination Tl-118 for Pancreatic Cancer Patients Who Are Starting Gemcitabine Treatment
NCT01509911
Start: 2012-01-31End: 2017-01-31Updated: 2016-02-05
Investigator's Initiated Phase II Study for Pancreatic Cancer Patients
NCT01659502
Start: 2013-12-31Target: 10Updated: 2013-12-05